Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

2022-04-11T16:24:18+00:00April 11th, 2022|

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study Survival time CONTACT US Summary [...]

Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy

2022-01-05T07:05:59+00:00January 5th, 2022|

Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy Survival Time CONTACT US Summary This study investigates the effect of chemotherapy [...]

Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer

2022-01-01T12:33:48+00:00January 1st, 2022|

Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer Gastric Cancer CONTACT US Summary [...]

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial

2021-12-23T09:01:44+00:00December 23rd, 2021|

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial Clinical Activity CONTACT US Summary In [...]

The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

2021-12-16T07:30:27+00:00December 16th, 2021|

The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors Detection of CIKs,CTLs and intracellular IFN-Y in T cells by flow cytometry [...]

Trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors

2021-12-05T08:15:41+00:00October 22nd, 2021|

Trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors Tumour shrinking with DCT CONTACT US Summary Patients with advanced [...]

Ilixadencel (allogeneic dendritic cells) : A Promising Treatment For GIST (advanced gastrointestinal stromal tumor) Patients

2021-12-05T07:58:49+00:00October 14th, 2021|

Ilixadencel (allogeneic dendritic cells) : A Promising Treatment For GIST (advanced gastrointestinal stromal tumor) Advanced gastrointestinal stromal tumor CONTACT US Summary Gastrointestinal stromal tumor (GIST) is most [...]

Improve Survival in Cancer Patients with Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy and Cytokine Induced Killer Cells

2021-12-05T08:18:42+00:00October 14th, 2021|

Improve Survival in Cancer Patients with Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy and Cytokine Induced Killer Cells Time to be disease free CONTACT US Summary Gastric and colorectal [...]

Go to Top